Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS)

Title
Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS)
Authors
Keywords
Androgen deprivation therapy, Anticancer agents, Bisphosphonates, Bone metastases, Prostate cancer, Skeletal-related events, Zoledronic acid
Journal
EUROPEAN UROLOGY
Volume 67, Issue 3, Pages 482-491
Publisher
Elsevier BV
Online
2014-02-20
DOI
10.1016/j.eururo.2014.02.014

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search